WEBULL
News
RVVTF
0.0075
NaN%
--
Weekly Report: what happened at RVVTF last week (1222-1226)?
Weekly Report · 12/29/2025 09:56
Weekly Report: what happened at RVVTF last week (1215-1219)?
Weekly Report · 12/22/2025 09:56
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
TipRanks · 12/15/2025 13:18
Weekly Report: what happened at RVVTF last week (1208-1212)?
Weekly Report · 12/15/2025 10:01
Weekly Report: what happened at RVVTF last week (1201-1205)?
Weekly Report · 12/08/2025 10:00
Weekly Report: what happened at RVVTF last week (1124-1128)?
Weekly Report · 12/01/2025 09:57
Weekly Report: what happened at RVVTF last week (1117-1121)?
Weekly Report · 11/24/2025 10:00
Revive Therapeutics Updates on Nerve Agent Countermeasure Study
TipRanks · 11/21/2025 17:33
Revive Therapeutics says nerve agent countmeasure study ‘remains in progress’
TipRanks · 11/21/2025 17:15
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Barchart · 11/21/2025 11:07
Weekly Report: what happened at RVVTF last week (1110-1114)?
Weekly Report · 11/17/2025 10:00
Weekly Report: what happened at RVVTF last week (1103-1107)?
Weekly Report · 11/10/2025 09:58
Weekly Report: what happened at RVVTF last week (1027-1031)?
Weekly Report · 11/03/2025 09:58
Weekly Report: what happened at RVVTF last week (1020-1024)?
Weekly Report · 10/27/2025 10:01
Weekly Report: what happened at RVVTF last week (1013-1017)?
Weekly Report · 10/20/2025 09:58
Weekly Report: what happened at RVVTF last week (1006-1010)?
Weekly Report · 10/13/2025 10:01
Weekly Report: what happened at RVVTF last week (0929-1003)?
Weekly Report · 10/06/2025 09:58
Weekly Report: what happened at RVVTF last week (0922-0926)?
Weekly Report · 09/29/2025 09:58
Weekly Report: what happened at RVVTF last week (0915-0919)?
Weekly Report · 09/22/2025 09:58
Revive Therapeutics Closes Second Tranche of Private Placement
TipRanks · 09/19/2025 21:41
More
Webull provides a variety of real-time RVVTF stock news. You can receive the latest news about Revive Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RVVTF
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).